Annexon Biosciences (ANNX): Wutah pendapatan kuartal marang kuartal

Logo korporat perusahaan Annexon, Inc. (ANNX)

Annexon, Inc. (ANNX) is expanding its portfolio with drugs designed to block immune proteins for rare brain and vision pathologies. The quarterly sales dynamics illustrate the market response, where the value 0.00 represents the current metric. This is underpinned by large-scale Phase 3 trials of the complement inhibitor ANX005 and a stable team of leading immunologists motivated by stock options to ensure the successful management of clinical trials.

ANNX (Annexon Biosciences Inc.) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 20.11.2026

Ringkesan rincian data analitis Annexon Biosciences (ANNX)

- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
Pambiji fundamental:ANNX - Annexon
Produk sing diprodhuksi Annexon

For the clinical-stage biotechnology company Annexon, Inc. (ANNX), the quarterly revenue trend serves as an indicator of operational activity. This metric is calculated as the percentage change in sales volume over the last three months relative to the previous period. This calculation allows investors to promptly track cash inflows from partnerships or licenses. The asset's current financial stability depends not on sales growth, but on its existing capital reserves.

Pesaing langsung

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Praxis Medicines|Tingkat wutah pendapatan sajrone kuartal Anavex AVXL|Wutah pendapatan kuartal marang kuartal CeriBell Corp (CBLL)|Owah-owahan dodolan kuartal marang kuartal PRTA|Wutah pendapatan triwulanan ALEC (Alector)|OMER: Wutah dodolan kuartal marang kuartal|NGNE - Wutah pendapatan kuartal marang kuartal|ACIU - Wutah pendapatan triwulanan|Voyager Corp (VYGR) - Wutah pendapatan kuartal marang kuartal|NMRA - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Scilex|TVGN (Tevogen Bio) - Owah-owahan dodolan kuartal marang kuartal|Wutah dodolan triwulanan ACOG (alphacognition.com)|Tingkat wutah dodolan sajrone kuartal Cognition Therapeutics, Inc.|Wutah pendapatan triwulanan IKT (Inhibikase Pharma)|Wutah pendapatan triwulanan Cassava Sciences, Inc. SAVA|ASRT - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Wutah pendapatan kuartal marang kuartal|OVID - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Acumen Pharmaceuticals, Inc|Wutah pendapatan kuartal marang kuartal CRVO|Wutah pendapatan triwulanan ATHE|Clene - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PEPG (pepgen.com)|JUNS: Wutah dodolan kuartal marang kuartal|RLMD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Firefly Neuroscience (AIFF)|Wutah dodolan triwulanan KLTO|NRSN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Reviva Pharmaceuticals Holdings (RVPH)|Wutah dodolan triwulanan MetaVia, Inc. MTVA|Wutah pendapatan kuartal marang kuartal NeurAxis NRXS|HSDT: Wutah dodolan kuartal marang kuartal|passagebio.com - Wutah pendapatan triwulanan|NEUP - Wutah pendapatan triwulanan|Minerva Neurosciences Corp (NERV) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ALZN (Alzamend Neuro)|Wutah pendapatan kuartal marang kuartal Cyclerion Therapeutics Inc. (CYCN)|Wutah pendapatan triwulanan Protagenic Therapeutics, Inc. (PTIX)|Wutah pendapatan triwulanan KTTA (Pasithea Therapeutics Corp)|CRGT - Wutah dodolan triwulanan|ATXI - Wutah pendapatan kuartal marang kuartal|BCLI: Wutah pendapatan kuartal marang kuartal|Cara Therapeutics (CARA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Chromocell Therapeutics Corp (CHRO)|Wutah dodolan triwulanan ELYM|Tingkat wutah pendapatan sajrone kuartal intracellulartherapies.com ITCI|Wutah pendapatan kuartal marang kuartal Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal NKGen NKGN|Wutah pendapatan triwulanan NeuroBo Pharmaceuticals Inc NRBO|SAGE: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Synaptogenix, Inc SNPX|TRVN: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal